Carolyn E. Cole

1.1k total citations
10 papers, 981 citations indexed

About

Carolyn E. Cole is a scholar working on Pharmacology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Carolyn E. Cole has authored 10 papers receiving a total of 981 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Carolyn E. Cole's work include Inflammatory mediators and NSAID effects (4 papers), Genetic factors in colorectal cancer (3 papers) and Estrogen and related hormone effects (2 papers). Carolyn E. Cole is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Genetic factors in colorectal cancer (3 papers) and Estrogen and related hormone effects (2 papers). Carolyn E. Cole collaborates with scholars based in United States. Carolyn E. Cole's co-authors include Russell F. Jacoby, Ronald A. Lubet, Karen Seibert, Gary J. Kelloff, Michael A. Newton, Gary J. Kelloff, Amy Moser, William F. Dove, Ernest T. Hawk and Ajit Kumar Verma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Gastrointestinal Endoscopy.

In The Last Decade

Carolyn E. Cole

8 papers receiving 943 citations

Peers

Carolyn E. Cole

PHARM

GENET

ONCOL

MB

CR

N S Paranka United States

Adil Akhtar United States

G D Stoner United States

Maria Simonsson Sweden

Wakashi Kitayama Japan

Steven Goldschmid United States

Giulia Piazzi Italy

Jayashri Kidao United States

Motoh Ohi Japan

Naveen Babbar United States

N S Paranka United States

Carolyn E. Cole

766 ×1.4

PHARM

425 ×1.3

GENET

253 ×0.8

ONCOL

334 ×1.3

MB

211 ×1.1

CR

Citations per year, relative to Carolyn E. Cole Carolyn E. Cole (= 1×) peers N S Paranka

Countries citing papers authored by Carolyn E. Cole

Since Specialization

Citations

This map shows the geographic impact of Carolyn E. Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolyn E. Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolyn E. Cole more than expected).

Fields of papers citing papers by Carolyn E. Cole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolyn E. Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolyn E. Cole. The network helps show where Carolyn E. Cole may publish in the future.

Co-authorship network of co-authors of Carolyn E. Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Carolyn E. Cole. A scholar is included among the top collaborators of Carolyn E. Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolyn E. Cole. Carolyn E. Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Tobi, Martin, Michael Kam, James S. Hatfield, et al.. (2007). An Anti-adenoma Antibody, Adnab-9, May Reflect the Risk for Neoplastic Progression in Familial Hamartomatous Polyposis Syndromes. Digestive Diseases and Sciences. 53(3). 723–729.

2.

Jacoby, Russell F., Carolyn E. Cole, Ernest T. Hawk, & Ronald A. Lubet. (2004). Ursodeoxycholate/Sulindac combination treatment effectively prevents intestinal adenomas in a mouse model of polyposis. Gastroenterology. 127(3). 838–844. 40 indexed citations

3.

Schwartz, Darren C., et al.. (2003). Diffuse Nodular Lymphoid Hyperplasia of the ColonPolyposis Syndrome or Normal Variant?. Gastrointestinal Endoscopy. 58(4). 630–632. 7 indexed citations

4.

Schwartz, Darren C., Carolyn E. Cole, Yeping Sun, & Russell F. Jacoby. (2003). Diffuse Nodular Lymphoid Hyperplasia of the Colon. Gastrointestinal Endoscopy. 58(4). 630–632. 9 indexed citations

5.

Jones, Brian, et al.. (2001). i-irasshai: An Immersive Cultural Learning Experience.. 93–105.

6.

Jacoby, Russell F., Carolyn E. Cole, Ronald A. Lubet, & Ming You. (2001). Effects of the nonspecific COX1 and COX2 inhibitor piroxicam and the ornithine decarboxylase inhibitor difluoromethylornithine (DFMO) on development of intestinal tumors in mice bearing germline alterations in the MSH2 or APC genes. Gastroenterology. 120(5). A121–A121. 3 indexed citations

7.

Jacoby, Russell F., Carolyn E. Cole, Kendra D. Tutsch, et al.. (2000). Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.. PubMed. 60(7). 1864–70. 130 indexed citations

8.

Halberg, Richard B., Peter D. Hoff, Amy Moser, et al.. (2000). Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiers. Proceedings of the National Academy of Sciences. 97(7). 3461–3466. 117 indexed citations

9.

Jacoby, Russell F., Karen Seibert, Carolyn E. Cole, Gary J. Kelloff, & Ronald A. Lubet. (2000). The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.. PubMed. 60(18). 5040–4. 413 indexed citations

10.

Jacoby, Russell F., D. J. Marshall, Michael A. Newton, et al.. (1996). Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.. PubMed. 56(4). 710–4. 262 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact